INFUSION SITE NECROSIS side effect
What is INFUSION SITE NECROSIS ?
Help Community - Describe Your Side Effect
Search FDA Side Effects
Ask Health Expert
INFUSION SITE NECROSIS and Recently Reported Side Effects
INFUSION SITE NECROSIS and 15 most Active Side Effect polls
INFUSION SITE NECROSIS and featured health surveys
Substances toxic to Health
Recent Hospital reviews
Comments about Side Effects
Hospital Quality reviews
Homecare Quality reviews
Heparin Side Effects Report #5613748-8
Pharmacist from UNITED STATES reported HEPARIN problem on Jan 18, 2008. Female patient was treated with HEPARIN. After drug was administered, patient experienced the following problems/side effects: infusion site necrosis, injection site erythema, injection site pallor, injection site vesicles, . HEPARIN dosage: unknown. Patient recovered.
Orencia Side Effects Report #5570517-5
ORENCIA problem was reported by a Physician from UNITED STATES on Nov 21, 2007. Female patient was diagnosed with rheumatoid arthritis and was treated with ORENCIA. After drug was administered, patient experienced the following problems/side effects: infusion site necrosis, . ORENCIA dosage: unknown. Patient recovered.
Mabthera Side Effects Report #5268668-8
Physician from NETHERLANDS reported MABTHERA problem on Mar 08, 2007. Female patient was diagnosed with mantle cell lymphoma and was treated with MABTHERA. After drug was administered, patient experienced the following problems/side effects: infusion site extravasation, infusion site necrosis, respiratory failure, skin graft, transplant failure, . MABTHERA dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISONE. Patient was hospitalized. Patient recovered.
Visudyne Side Effects Report #5357138-4
VISUDYNE problem was reported by a Physician from FRANCE on May 28, 2007. Female patient, 75 years of age, was treated with VISUDYNE. After drug was administered, patient experienced the following problems/side effects: infusion site erythema, infusion site extravasation, infusion site necrosis, infusion site oedema, . VISUDYNE dosage: 4.77 ML DAILY IV. During the same period patient was treated with ALDACTONE, LOXEN, DIDRONEL. Patient recovered.